Marshall Wace’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Marshall Wace’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-22,939	Closed	-$1.2M	–	2412
2020 Q3	$1.2M	Buy	+22,939	New	+$950K	0.01%	959
2020 Q1	–	Sell	-103,790	Closed	-$2.05M	–	2262
2019 Q4	$2.05M	Buy	+103,790	New	+$1.66M	0.01%	812
2019 Q1	–	Sell	-150,521	Closed	-$1.66M	–	2203
2018 Q4	$1.66M	Buy	+150,521	New	+$2.09M	0.02%	771
2016 Q2	–	Sell	-427,551	Closed	-$3.95M	–	1247
2016 Q1	$3.95M	Buy	+427,551	New	+$4.6M	0.04%	397

Marshall Wace's MNTA Position: Q4 2020 in Review

Marshall Wace sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 22,939 shares — an estimated $1.2M sold.

Marshall Wace first reported a position in MNTA in Q1 2016 and held it in 4 quarters. The position peaked at $3.95M in Q1 2016. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Marshall Wace reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Marshall Wace sold 22,939 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.2M.
Marshall Wace first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2016 and held it in 4 quarters.
Marshall Wace's Momenta Pharmaceuticals, Inc. position peaked at $3.95M in Q1 2016.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.